Margetuximab-cmkb
Restricted to use by Oncology in the outpatient setting. Reimbursement and insurance certification or PAP eligibility will be reviewed prior to initiation of therapy.
Reviewed: April 2022 (Margenza)
Margetuximab-cmkb (Margenza)
Restricted to use by Oncology in the outpatient setting. Reimbursement and insurance certification or PAP eligibility will be reviewed prior to initiation of therapy.
Reviewed: April 2022 (Margenza)
Margetuximab-cmkb (Margenza)